Once a "virtual company", it has grown over a decade into the most international force in stem cells

Article Abstract:

Stem Cell Sciences (SCS) is the most global of any stem cell company having corporate research and development centers in the UK, Japan, and Australia. SCS, set up by Peter Mountford, chief executive of SCS in his native Australia as a 'Virtual company' in the year 1994 is further planning to set up a US operation in the year 2005.

Australia, Strategy & planning, Management dynamics, Management, Planning, Company Profile, Company business management, Company business planning, Stem Cell Sciences

---

Tough cell to investors

Article Abstract:

Venture capitalists totally understand the rich potential of stem cells, although many reasons make them hesitate to invest. Even though stem cells have the potential to provide therapies for a huge range of ills, it is proving hard to attract the investment needed to develop them.

United States, Product development, Forecasts, trends, outlooks, Financial management, Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Finance, Forecasts and trends, Company investment, Investments, Market trend/market analysis, Company financing

---

Similar abstracts:

• Abstracts: Intranet based system for a product innovation management process. Comparative study of product innovation systems
• Abstracts: Fahrenheit 2777: 9/11 has generated the mother of all conspiracy theories. Darwin on the right
• Abstracts: In Singapore, a company with ambitious goals leads a "privileged existence". The former patent powerhouse works on new therapies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.